ALLMedicine™ Glucose Tolerance Testing Center
Research & Reviews 327 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004604
PloS One; Cao S, Jurczak MJ et. al.
Mar 11th, 2023 - Cyclin-dependent kinase 1 (CDK1)/cyclin B1 phosphorylates many of the same substrates as mTORC1 (a key regulator of glucose metabolism), including the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Only mitotic CDK1 phosphorylates 4E-...
https://clinicaltrials.gov/ct2/show/NCT02520609
Mar 10th, 2023 - Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in the Western world, and is a leading cause of liver-related morbidity and mortality. Excessive caloric intake and specific nutritional components have been implicated ...
https://doi.org/10.1016/j.jcjd.2023.02.002
Canadian Journal of Diabetes; Potter KJ, Coriati A et. al.
Mar 6th, 2023 - Our aim in this study was to identify challenges and gaps in Canadian practices in screening, diagnosis and treatment of cystic fibrosis-related diabetes (CFRD), with the goal of informing a Canadian-specific guideline for CFRD. We conducted an on...
https://clinicaltrials.gov/ct2/show/NCT03650712
Mar 3rd, 2023 - A. Hypotheses and Specific Aims: Cystic Fibrosis Related Diabetes Mellitus (CFRD) has been identified by the CF community as one of the top ten priorities for CF research1. In CF, clinical decline due to dysglycemia begins early, prior to the diag...
https://doi.org/10.1089/jwh.2022.0305
Journal of Women's Health (2002); Wilkie GL, Leftwich HK et. al.
Feb 17th, 2023 - Objective: The aim of this study was to characterize current diabetes screening practices in the first trimester of pregnancy in the United States, evaluate patient characteristics and risk factors associated with early diabetes screening, and com...
Drugs 16 results see all →
Clinicaltrials.gov 51 results
https://clinicaltrials.gov/ct2/show/NCT02520609
Mar 10th, 2023 - Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in the Western world, and is a leading cause of liver-related morbidity and mortality. Excessive caloric intake and specific nutritional components have been implicated ...
https://clinicaltrials.gov/ct2/show/NCT03650712
Mar 3rd, 2023 - A. Hypotheses and Specific Aims: Cystic Fibrosis Related Diabetes Mellitus (CFRD) has been identified by the CF community as one of the top ten priorities for CF research1. In CF, clinical decline due to dysglycemia begins early, prior to the diag...
https://clinicaltrials.gov/ct2/show/NCT05058690
Feb 8th, 2023 - This multicentre prospective study will evaluate the ability of the FatHealth technology to correctly identify individuals with pre-diabetes and diabetes, validating the technology against the current gold-standard diagnostic method, oral glucose ...
https://clinicaltrials.gov/ct2/show/NCT04199676
Jan 26th, 2023 - Gestational diabetes affects approximately 5-10% of pregnancies and its prevalence continues to increase as rates of obesity and metabolic disease increase in reproductive age women. Women diagnosed with gestational diabetes carry an increased ris...
https://clinicaltrials.gov/ct2/show/NCT00445627
Jan 13th, 2023 - Background: Type 2 diabetes mellitus (T2DM) is a condition characterized by insulin resistance and progressive failure of the insulin-secreting beta-cells. Previously considered a disease of adults, it is now becoming increasingly prevalent in chi...
News 27 results
https://www.medpagetoday.com/neurology/sleepdisorders/97048
Feb 7th, 2022 - More sleep was linked with fewer calories consumed, a single-center randomized clinical trial showed. Compared with controls, young adults who were overweight and habitually slept less than 6.5 hours a night slept an extra 1.2 hours on average aft...
https://www.mdedge.com/cardiology/article/235252/cad-atherosclerosis/gestational-diabetes-carries-cvd-risk-years-later
Richard Mark Kirkner
Feb 1st, 2021 - Women who’ve had gestational diabetes are 40% more likely to develop coronary artery calcification later in life than are women haven’t, and attaining normal glycemic levels doesn’t diminish their midlife risk for atherosclerotic cardiovascular di.
https://www.mdedge.com/internalmedicine/article/218148/obstetrics/gestational-diabetes-early-postpartum-glucose-testing?channel=39313
Kari Oakes
Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.
https://www.mdedge.com/obgyn/article/218148/obstetrics/gestational-diabetes-early-postpartum-glucose-testing-winner
Kari Oakes
Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.
https://www.mdedge.com/pediatrics/article/202556/diabetes/teplizumab-delays-onset-type-1-diabetes
Bianca Nogrady
Jun 9th, 2019 - The monoclonal antibody teplizumab may delay the onset of type 1 diabetes in individuals at high risk, according to research presented at the annual scientific sessions of the American Diabetes Association. In this study, 76 first-degree relatives.